Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

Pharmacokinetics of enteric coated mycophenolate sodium in lupus nephritis (POEMSLUN).

Ranganathan D, Abdul-Aziz MH, John GT, McWhinney BC, Fassett RG, Healy H, Kubler P, Lim A, Lipman J, Purvey M, Roberts M, Reyaldeen R, Ungerer J, Roberts JA.

Ther Drug Monit. 2019 Jun 18. doi: 10.1097/FTD.0000000000000658. [Epub ahead of print]

PMID:
31219949
2.

Human Tissue-Resident Mucosal-Associated Invariant T (MAIT) Cells in Renal Fibrosis and CKD.

Law BMP, Wilkinson R, Wang X, Kildey K, Giuliani K, Beagley KW, Ungerer J, Healy H, Kassianos AJ.

J Am Soc Nephrol. 2019 Jun 11. pii: ASN.2018101064. doi: 10.1681/ASN.2018101064. [Epub ahead of print]

PMID:
31186283
3.

Impact of the pattern of interstitial lung disease on mortality in rheumatoid arthritis: A systematic literature review and meta-analysis.

Singh N, Varghese J, England BR, Solomon JJ, Michaud K, Mikuls TR, Healy HS, Kimpston EM, Schweizer ML.

Semin Arthritis Rheum. 2019 May 15. pii: S0049-0172(18)30639-5. doi: 10.1016/j.semarthrit.2019.04.005. [Epub ahead of print]

PMID:
31153706
4.

Pigment Nephropathy: Novel Insights into Inflammasome-Mediated Pathogenesis.

Giuliani KTK, Kassianos AJ, Healy H, Gois PHF.

Int J Mol Sci. 2019 Apr 23;20(8). pii: E1997. doi: 10.3390/ijms20081997. Review.

5.

Natural Killer Cells in Kidney Health and Disease.

Turner JE, Rickassel C, Healy H, Kassianos AJ.

Front Immunol. 2019 Mar 26;10:587. doi: 10.3389/fimmu.2019.00587. eCollection 2019. Review.

6.

The challenges to public health nurse practice in rural Ireland.

Farrelly T, Flaherty S, Healy H.

Public Health Nurs. 2019 May;36(3):341-347. doi: 10.1111/phn.12595. Epub 2019 Feb 27.

PMID:
30815907
7.

Chronic kidney disease, Queensland: Profile of patients with chronic kidney disease from regional Queensland, Australia: A registry report.

Venuthurupalli SK, Healy H, Fassett R, Cameron A, Wang Z, Hoy WE.

Nephrology (Carlton). 2019 Jan 20. doi: 10.1111/nep.13567. [Epub ahead of print]

PMID:
30663166
8.

The Kidney Supportive Care programme: characteristics of patients referred to a new model of care.

Purtell L, Sowa PM, Berquier I, Scuderi C, Douglas C, Taylor B, Kramer K, Hoy W, Healy H, Bonner A.

BMJ Support Palliat Care. 2018 Dec 4. pii: bmjspcare-2018-001630. doi: 10.1136/bmjspcare-2018-001630. [Epub ahead of print]

PMID:
30514718
9.

The Role of Oxidative Stress and Inflammation in Acute Oxalate Nephropathy Associated With Ethylene Glycol Intoxication.

Wilson GJ, Gois PHF, Zhang A, Wang X, Law BMP, Kassianos AJ, Healy HG.

Kidney Int Rep. 2018 Jun 11;3(5):1217-1221. doi: 10.1016/j.ekir.2018.05.005. eCollection 2018 Sep. No abstract available.

10.

Body mass index in an Australian population with chronic kidney disease.

Chan S, Cameron A, Wang Z, Venuthurupalli SK, Tan KS, Healy HG, Hoy WE.

BMC Nephrol. 2018 Aug 20;19(1):209. doi: 10.1186/s12882-018-1006-2.

11.

Metasynthesis of Patient Attitudes Toward Bone Densitometry.

Seaman AT, Steffen M, Doo T, Healy HS, Solimeo SL.

J Gen Intern Med. 2018 Oct;33(10):1796-1804. doi: 10.1007/s11606-018-4587-3. Epub 2018 Jul 27.

PMID:
30054881
12.

Effector γδ T cells in human renal fibrosis and chronic kidney disease.

Law BM, Wilkinson R, Wang X, Kildey K, Lindner M, Beagley K, Healy H, Kassianos AJ.

Nephrol Dial Transplant. 2019 Jan 1;34(1):40-48. doi: 10.1093/ndt/gfy098.

PMID:
29897565
13.

Health service utilisation during the last year of life: a prospective, longitudinal study of the pathways of patients with chronic kidney disease stages 3-5.

Chambers S, Healy H, Hoy WE, Kark A, Ratanjee S, Mitchell G, Douglas C, Yates P, Bonner A.

BMC Palliat Care. 2018 Apr 5;17(1):57. doi: 10.1186/s12904-018-0310-8.

14.

Tracking patients with advanced kidney disease in the last 12 months of life.

Bonner A, Chambers S, Healy H, Hoy W, Mitchell G, Kark A, Ratanjee S, Yates P.

J Ren Care. 2018 Jun;44(2):115-122. doi: 10.1111/jorc.12239. Epub 2018 Feb 28.

PMID:
29493102
15.

CKD Screening and Surveillance in Australia: Past, Present, and Future.

Venuthurupalli SK, Hoy WE, Healy HG, Cameron A, Fassett RG.

Kidney Int Rep. 2017 Oct 6;3(1):36-46. doi: 10.1016/j.ekir.2017.09.012. eCollection 2018 Jan. Review.

16.

Spectrum (characteristics) of patients with chronic kidney disease (CKD) with increasing age in a major metropolitan renal service.

Mahmood U, Healy HG, Kark A, Cameron A, Wang Z, Abeysekera R, Hoy WE.

BMC Nephrol. 2017 Dec 28;18(1):372. doi: 10.1186/s12882-017-0781-5.

17.

The increasing rates of acute interstitial nephritis in Australia: a single centre case series.

Wilson GJ, Kark AL, Francis LP, Hoy W, Healy HG, Mallett AJ.

BMC Nephrol. 2017 Oct 31;18(1):329. doi: 10.1186/s12882-017-0747-7.

18.

CKD.QLD: establishment of a chronic kidney disease [CKD] registry in Queensland, Australia.

Venuthurupalli SK, Hoy WE, Healy HG, Cameron A, Fassett RG.

BMC Nephrol. 2017 Jun 7;18(1):189. doi: 10.1186/s12882-017-0607-5.

19.

Unique molecular profile of exosomes derived from primary human proximal tubular epithelial cells under diseased conditions.

Wang X, Wilkinson R, Kildey K, Potriquet J, Mulvenna J, Lobb RJ, Möller A, Cloonan N, Mukhopadhyay P, Kassianos AJ, Healy H.

J Extracell Vesicles. 2017 Apr 21;6(1):1314073. doi: 10.1080/20013078.2017.1314073. eCollection 2017.

20.

A Randomized Controlled Trial to Determine the Appropriate Time to Initiate Peritoneal Dialysis after Insertion of Catheter (Timely PD Study).

Ranganathan D, John GT, Yeoh E, Williams N, O'Loughlin B, Han T, Jeyaseelan L, Ramanathan K, Healy H.

Perit Dial Int. 2017 Jul-Aug;37(4):420-428. doi: 10.3747/pdi.2016.00066. Epub 2017 Apr 13.

PMID:
28408711
21.

Ethambutol Is Cleared by a Contemporary High-Flux Hemodialyzer, and Drug Monitoring Ensures Safety and Therapeutic Effect.

Chew R, Jongbloed S, Jegatheesan D, Healy H, Ta K, Ungerer J, McWhinney B, Donovan P, Woods ML.

Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e01988-16. doi: 10.1128/AAC.01988-16. Print 2017 Jun.

22.

Interferon-γ production by tubulointerstitial human CD56bright natural killer cells contributes to renal fibrosis and chronic kidney disease progression.

Law BMP, Wilkinson R, Wang X, Kildey K, Lindner M, Rist MJ, Beagley K, Healy H, Kassianos AJ.

Kidney Int. 2017 Jul;92(1):79-88. doi: 10.1016/j.kint.2017.02.006. Epub 2017 Apr 8.

PMID:
28396119
23.

Everolimus-induced tubular toxicity in non-renal cancer.

Chan S, Francis LP, Kark AL, Bigby KJ, Healy HG, Chern BW.

Intern Med J. 2016 Dec;46(12):1454-1455. doi: 10.1111/imj.13284. No abstract available.

PMID:
27981761
24.

A multidisciplinary renal genetics clinic improves patient diagnosis.

Mallett A, Fowles LF, McGaughran J, Healy H, Patel C.

Med J Aust. 2016 Feb 1;204(2):58-9. No abstract available.

PMID:
26821098
25.

Development and Evaluation of a Scored Sodium Questionnaire-Screening Form for Kidney Disease Patients.

Ross L, Chong SH, Mason B, Healy H.

J Ren Nutr. 2016 May;26(3):159-67. doi: 10.1053/j.jrn.2015.10.006. Epub 2016 Jan 6.

PMID:
26776250
26.

A protocol for the identification and validation of novel genetic causes of kidney disease.

Mallett A, Patel C, Maier B, McGaughran J, Gabbett M, Takasato M, Cameron A, Trnka P, Alexander SI, Rangan G, Tchan MC, Caruana G, John G, Quinlan C, McCarthy HJ, Hyland V, Hoy WE, Wolvetang E, Taft R, Simons C, Healy H, Little M.

BMC Nephrol. 2015 Sep 15;16:152. doi: 10.1186/s12882-015-0148-8.

27.

The Mechanisms of Human Renal Epithelial Cell Modulation of Autologous Dendritic Cell Phenotype and Function.

Sampangi S, Kassianos AJ, Wang X, Beagley KW, Klein T, Afrin S, Healy H, Wilkinson R.

PLoS One. 2015 Jul 31;10(7):e0134688. doi: 10.1371/journal.pone.0134688. eCollection 2015.

28.

Genomics in the renal clinic - translating nephrogenetics for clinical practice.

Mallett A, Corney C, McCarthy H, Alexander SI, Healy H.

Hum Genomics. 2015 Jun 24;9:13. doi: 10.1186/s40246-015-0035-1.

29.

Human proximal tubule epithelial cells modulate autologous B-cell function.

Sampangi S, Wang X, Beagley KW, Klein T, Afrin S, Healy H, Wilkinson R, Kassianos AJ.

Nephrol Dial Transplant. 2015 Oct;30(10):1674-83. doi: 10.1093/ndt/gfv242. Epub 2015 Jun 8.

PMID:
26058593
30.

Fractalkine-CX3CR1-dependent recruitment and retention of human CD1c+ myeloid dendritic cells by in vitro-activated proximal tubular epithelial cells.

Kassianos AJ, Wang X, Sampangi S, Afrin S, Wilkinson R, Healy H.

Kidney Int. 2015 Jun;87(6):1153-63. doi: 10.1038/ki.2014.407. Epub 2015 Jan 14.

PMID:
25587706
31.

The prevalence and epidemiology of genetic renal disease amongst adults with chronic kidney disease in Australia.

Mallett A, Patel C, Salisbury A, Wang Z, Healy H, Hoy W.

Orphanet J Rare Dis. 2014 Jun 30;9:98. doi: 10.1186/1750-1172-9-98.

32.

Taming the chronic kidney disease epidemic: a global view of surveillance efforts.

Radhakrishnan J, Remuzzi G, Saran R, Williams DE, Rios-Burrows N, Powe N; CDC-CKD Surveillance Team, Brück K, Wanner C, Stel VS; European CKD Burden Consortium, Venuthurupalli SK, Hoy WE, Healy HG, Salisbury A, Fassett RG; CKD.QLD group, O'Donoghue D, Roderick P, Matsuo S, Hishida A, Imai E, Iimuro S.

Kidney Int. 2014 Aug;86(2):246-50. doi: 10.1038/ki.2014.190. Epub 2014 Jun 4.

33.

Serum 25-hydroxy vitamin D concentrations are more deficient/insufficient in peritoneal dialysis than haemodialysis patients in a sunny climate.

Hanna K, Fassett RG, Gill E, Healy H, Kimlin M, Ross L, Ash S.

J Hum Nutr Diet. 2015 Jun;28(3):209-18. doi: 10.1111/jhn.12234. Epub 2014 Apr 11.

PMID:
24720834
34.

Complexities during transitions to adulthood for youth with disabilities: person-environment interactions.

Stewart D, Law M, Young NL, Forhan M, Healy H, Burke-Gaffney J, Freeman M.

Disabil Rehabil. 2014;36(23):1998-2004. doi: 10.3109/09638288.2014.885994. Epub 2014 Feb 10.

PMID:
24506663
35.

Laser capture microdissection and multiplex-tandem PCR analysis of proximal tubular epithelial cell signaling in human kidney disease.

Wilkinson R, Wang X, Kassianos AJ, Zuryn S, Roper KE, Osborne A, Sampangi S, Francis L, Raghunath V, Healy H.

PLoS One. 2014 Jan 27;9(1):e87345. doi: 10.1371/journal.pone.0087345. eCollection 2014.

36.

Development and validation of a dietary screening tool for high sodium consumption in Australian renal patients.

Mason B, Ross L, Gill E, Healy H, Juffs P, Kark A.

J Ren Nutr. 2014 Mar;24(2):123-34.e1-3. doi: 10.1053/j.jrn.2013.10.004. Epub 2014 Jan 3.

PMID:
24394445
37.

Splenunculus masquerading as a neuroendocrine tumor of the pancreatic allograft in a kidney-pancreas recipient.

Mohandas JT, Ravi Kumar AS, Ranganathan D, Healy H, Huang YT, O'Loughlin B, Chapman J, John GT.

Transplantation. 2013 Oct 27;96(8):e59-62. doi: 10.1097/TP.0b013e3182a80c67. No abstract available.

PMID:
24132115
38.

Increased tubulointerstitial recruitment of human CD141(hi) CLEC9A(+) and CD1c(+) myeloid dendritic cell subsets in renal fibrosis and chronic kidney disease.

Kassianos AJ, Wang X, Sampangi S, Muczynski K, Healy H, Wilkinson R.

Am J Physiol Renal Physiol. 2013 Nov 15;305(10):F1391-401. doi: 10.1152/ajprenal.00318.2013. Epub 2013 Sep 18.

39.

A Protocol for the Pharmacokinetics of Enteric Coated Mycophenolate Sodium in Lupus Nephritis (POEMSLUN): an open-label, randomised controlled trial.

Ranganathan D, John GT, Healy H, Roberts MJ, Fassett RG, Lipman J, Kubler P, Ungerer J, McWhinney BC, Lim A, Purvey M, Reyaldeen R, Roberts JA.

BMJ Open. 2013 Aug 7;3(8). pii: e003511. doi: 10.1136/bmjopen-2013-003511.

40.

ANZSN renal supportive care 2013: opinion pieces [corrected].

Brown MA, Crail SM, Masterson R, Foote C, Robins J, Katz I, Josland E, Brennan F, Stallworthy EJ, Siva B, Miller C, Urban AK, Sajiv C, Glavish RN, May S, Langham R, Walker R, Fassett RG, Morton RL, Stewart C, Phipps L, Healy H, Berquier I.

Nephrology (Carlton). 2013 Jun;18(6):401-454. doi: 10.1111/nep.12065. Review. No abstract available. Erratum in: Nephrology (Carlton). 2014 Mar;19(3):175.

PMID:
23586687
41.

Case Vignettes.

Healy H, Berquier I, Crail SM.

Nephrology (Carlton). 2013 Apr 16. doi: 10.1111/nep.12088. [Epub ahead of print]

PMID:
23586683
42.

CKD.QLD: chronic kidney disease surveillance and research in Queensland, Australia.

Venuthurupalli SK, Hoy WE, Healy HG, Salisbury A, Fassett RG; CKD.QLD group.

Nephrol Dial Transplant. 2012 Oct;27 Suppl 3:iii139-45. doi: 10.1093/ndt/gfs258.

43.

Factors associated with chronic kidney disease progression in Australian nephrology practices.

Boudville N, Kemp A, Moody H, Fassett RG, Pedagogos E, Nelson C, Healy H, Mangos G, Kirkland G, Kay T, Champion de Crespigny P, Hoffman D, Waugh D; eKiDNAA.

Nephron Clin Pract. 2012;121(1-2):c36-41. doi: 10.1159/000342375. Epub 2012 Oct 19.

PMID:
23095346
44.

Seeking counsellors who have undergone nurse training.

Healy H.

Nurs Stand. 2012 Oct 10;27(6):32. doi: 10.7748/ns.27.6.32.s52.

PMID:
28072054
45.

Pharmacokinetics of intraperitoneal gentamicin in peritoneal dialysis patients with peritonitis (GIPD study).

Varghese JM, Roberts JA, Wallis SC, Boots RJ, Healy H, Fassett RG, Lipman J, Ranganathan D.

Clin J Am Soc Nephrol. 2012 Aug;7(8):1249-56. doi: 10.2215/CJN.12211211. Epub 2012 Jun 14.

46.

Human proximal tubule epithelial cells modulate autologous dendritic cell function.

Kassianos AJ, Sampangi S, Wang X, Roper KE, Beagley K, Healy H, Wilkinson R.

Nephrol Dial Transplant. 2013 Feb;28(2):303-12. doi: 10.1093/ndt/gfs136. Epub 2012 May 18.

PMID:
22610986
47.

Longitudinal Evaluation of Transition Services ("LETS Study"): protocol for outcome evaluation.

Tsybina I, Kingsnorth S, Maxwell J, Bayley M, Lindsay S, McKeever P, Colantonio A, Hamdani Y, Healy H, Macarthur C.

BMC Pediatr. 2012 May 15;12:51. doi: 10.1186/1471-2431-12-51.

48.

Sustained remission of systemic lupus erythematosus related calciphylaxis.

Mallett A, John GT, Ranganathan D, Kark A, Berquier I, Casey J, Healy H, Francis L.

Lupus. 2012 Apr;21(4):441-4. doi: 10.1177/0961203311425526. Epub 2011 Oct 26.

PMID:
22031536
49.

Ibuprofen-related renal tubular acidosis in pregnancy.

Mallett A, Lynch M, John GT, Healy H, Lust K.

Obstet Med. 2011 Sep;4(3):122-4. doi: 10.1258/om.2011.110041. Epub 2011 Aug 23.

50.

The emerging role of nuclear factor kappa B in renal cell carcinoma.

Morais C, Gobe G, Johnson DW, Healy H.

Int J Biochem Cell Biol. 2011 Nov;43(11):1537-49. doi: 10.1016/j.biocel.2011.08.003. Epub 2011 Aug 12. Review.

PMID:
21854869

Supplemental Content

Support Center